Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DABIGATRAN | 150MG | CAPSULE | Resolved | 2024-06-14 | 2024-09-20 | 230558 |
| APO-DABIGATRAN | 110MG | CAPSULE | Resolved | 2024-06-14 | 2024-09-20 | 230561 |
| APO-DABIGATRAN | 150MG | CAPSULE | Resolved | 2024-07-12 | 2024-07-19 | 232842 |
| APO-DABIGATRAN | 150MG | CAPSULE | Actual shortage | 2024-10-24 | 2024-10-24 | 241059 |
| APO-DABIGATRAN | 110MG | CAPSULE | Actual shortage | 2024-11-15 | 2024-11-15 | 243170 |
| APO-DABIGATRAN | 110MG | CAPSULE | Resolved | 2024-12-05 | 2025-01-24 | 244888 |
| APO-DABIGATRAN | 110MG | CAPSULE | Resolved | 2025-04-10 | 2025-05-23 | 254858 |
| APO-DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2023-09-01 | 2024-01-05 | 203563 |
| APO-DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2023-10-27 | 2024-01-05 | 208370 |
| APO-DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2023-11-06 | 2024-01-05 | 209333 |
| APO-DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2024-03-08 | 2024-04-19 | 221678 |
| APO-DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2025-09-11 | 2025-11-28 | 267020 |
| APO-DAPAGLIFLOZIN-METFORMIN | 1000MG 5MG | TABLET | Resolved | 2024-06-20 | 2024-08-02 | 231020 |
| APO-DAPAGLIFLOZIN-METFORMIN | 850MG 5MG | TABLET | Resolved | 2024-12-05 | 2024-12-13 | 244918 |
| APO-DARIFENACIN | 7.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-10-01 | 2022-01-24 | 146503 |
| APO-DARIFENACIN | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-01-14 | 2022-02-03 | 152758 |
| APO-DARIFENACIN | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-01 | 2024-07-05 | 212368 |
| APO-DARIFENACIN | 7.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-15 | 2024-10-11 | 213547 |
| APO-DARUNAVIR | 600MG | TABLET | Resolved | 2020-06-04 | 2020-06-26 | 116530 |
| APO-DARUNAVIR | 600MG | TABLET | Resolved | 2024-06-06 | 2024-10-07 | 229752 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 |